Pharma VC Funds

KKR, a global investment giant established in 1976, boasts a diverse and robust portfolio. Among their notable tech investments are GoDaddy, FanDuel, and BMC Software, while in energy and healthcare, they back EP Energy, Ridge Natural Resources, BridgeBio Pharma, and Coastal Carolina Hospital. Their industry focus is broad, spanning private equity, infrastructure, real estate, and credit, with a strong emphasis on sustainability and long-term value creation. Geographically, KKR's investments stretch across the Americas, Europe, and Asia Pacific, reflecting their global reach. Their strategy emphasizes patient, disciplined investing, leveraging deep industry knowledge and a network of expert resources to drive growth in their portfolio companies. They are known for leading investment rounds and typically target companies with substantial growth potential and innovative capabilities. KKR often writes large checks, frequently exceeding $100 million, and takes an active role in guiding their investments, offering strategic advice and operational support. Companies looking to attract KKR's interest should highlight their growth potential, solid business models, and alignment with KKR’s strategic objectives. The firm’s leadership includes Henry Kravis and George Roberts, who bring decades of investment expertise and are based in New York. KKR’s team of over 750 investment professionals worldwide ensures that each investment benefits from specialized expertise and strategic insights. For startups and businesses, aligning proposals with KKR’s focus on sustainable growth and value creation is key to engaging successfully with this investment powerhouse.

Kleiner Perkins, based in Menlo Park, California, is one of Silicon Valley’s most storied venture capital firms, known for its early investments in groundbreaking technology companies. Founded in 1972, the firm has backed over 900 ventures, including iconic names like Amazon, Google, and Genentech​. Kleiner Perkins invests primarily in early-stage companies across a broad range of industries including technology, healthcare, and sustainability. Their investment strategy is characterized by partnering closely with founders from the inception of their companies through to IPO and beyond. This approach has led to successful exits such as Netscape, Cerent, and more recently, Google and Amazon​. The firm has seen significant leadership changes in recent years, with the addition of partners like Mamoon Hamid and Ilya Fushman, who have driven a renewed focus on early-stage investments. Recent funds include the $700 million KP19 and the $750 million KP Select fund, which aim to support high-growth companies in sectors like enterprise software, consumer tech, and fintech​. Kleiner Perkins continues to leverage its deep network and extensive experience to support its portfolio companies in areas such as talent acquisition, go-to-market strategies, and marketing. This hands-on approach, combined with their strategic investments, ensures they remain a key player in fostering innovation and driving growth in the tech ecosystem.

Kli Capital, formerly known as BNSG Capital, is a venture capital firm founded in 2014 by Shmuel Gniwisch. Based in New York, the firm focuses on investing in early-stage startups across the U.S., Israel, and emerging markets. Kli Capital targets sectors including healthtech, insurtech/fintech, and consumer products. The firm has made 79 investments and has seen 18 exits. Notable portfolio companies include Hippo Insurance, Imagen Technologies, mPharma, Nym Health, and Cycognito. Kli Capital has recently closed its third fund, aiming to invest $750k to $1.5 million in pre-seed and seed-stage companies. This new fund emphasizes the firm's strategy of backing ambitious founders and providing comprehensive support beyond financial capital. Kli Capital's team includes key figures such as founder and managing partner Shmuel Gniwisch and partner Elias Davis. The firm prides itself on its hands-on approach, leveraging its operational experience to help startups achieve significant growth and success.

KohFounders is a Los Angeles-based pre-seed venture capital firm founded in 2014, specializing in supporting emerging ecosystems and early-stage technology startups. The firm focuses on industries such as healthcare tech, fintech, edtech, agtech, and frontier tech, targeting mission-driven founders who are building scalable and impactful businesses. KohFounders is known for taking a hands-on approach, helping entrepreneurs before they raise institutional capital. With a diverse portfolio, KohFounders has backed notable companies like K Health, a unicorn in the healthcare technology space, as well as Wellth, Starfish Space, and Andrena, which operates in the internet service sector. The firm has also seen several successful exits, including SimpleHealth and Amobee, highlighting its focus on high-growth companies with strong market potential. Led by Founding Partner Bong Koh, who brings extensive experience from previous roles at companies like Photobucket and Brand Networks, KohFounders provides more than just capital—offering mentorship, strategic guidance, and access to a wide network. The team works closely with founders to scale their businesses and achieve long-term success.

Kombo Ventures is a diversified investment and holding company founded by Kevin Gould, specializing in consumer brands, technology, and entertainment. With a focus on launching and scaling direct-to-consumer businesses, Kombo Ventures has co-founded high-growth brands like Glamnetic, a top press-on nail and magnetic eyelash company, and INH Hair, a hair extensions brand, both of which have gained significant traction in the beauty industry. These brands have generated impressive revenues and secured distribution deals with major retailers like Sephora, Ulta, and Target. In addition to launching new ventures, Kombo Ventures also acquires and scales existing brands, utilizing its best-in-class infrastructure to help businesses reach new heights. The company is known for identifying emerging trends and leveraging its extensive network in the digital creator and e-commerce spaces to create defensible business models. Through its AngelList syndicate, Kombo provides access to exclusive deal flow for its limited partners, deploying millions in investments across various industries. Kombo’s notable investments and exits include Gyft (acquired by First Data), Whistle (acquired by Mars), and Draft Kings, which went public. Kombo Ventures also operates in the entertainment industry, managing talent and helping creators build long-term growth through business ventures. With its deep expertise in digital marketing and consumer behavior, Kombo Ventures is strategically positioned to continue building and investing in the next wave of influential brands in the digital and consumer sectors. This forward-thinking approach has made the firm a key player in both the venture capital and entertainment spaces.

The Korea Investment Corporation (KIC) is South Korea's sovereign wealth fund, established in 2005 to manage and grow the nation’s foreign reserves. Based in Seoul, KIC operates globally with assets under management totaling $189.4 billion as of 2023. The fund's core mission is to preserve and enhance the purchasing power of South Korea’s sovereign assets through strategic investments across traditional and alternative asset classes. KIC’s investment portfolio is diverse, comprising equities, fixed income, private equity, real estate, infrastructure, and hedge funds. Recently, there has been a notable shift towards increasing allocations in alternative assets, which now make up around 22% of the total portfolio. This strategic move aims to reduce volatility and capture long-term value, reflecting the fund's commitment to adapting to changing global market dynamics. The fund reported an 11.59% return on total assets in 2023, underscoring its effective asset allocation and risk management strategies. Governed by a structured management philosophy, KIC emphasizes long-term investment, risk control, and sustainable growth. The fund also actively engages in initiatives to support South Korea's financial industry, including training programs to develop expertise in international finance. KIC is led by CEO Park Il Young, who, along with a seasoned leadership team, continues to guide the fund towards achieving stable, long-term growth while maintaining a robust global presence.

Korelya Capital, founded in 2016 by Fleur Pellerin and Antoine Dresch, is a venture capital firm based in Paris with a focus on supporting the growth of European technology startups. The firm leverages its connections to the Asian market through its backing by Naver, the South Korean internet giant. Korelya Capital specializes in late-stage investments, targeting sectors such as AI, digital health, and consumer technology. Notable investments include Ledger, a leading provider of security and infrastructure solutions for cryptocurrencies; Wallapop, a peer-to-peer marketplace; and Upway, a refurbished e-bike marketplace. Other significant investments are in companies like Myrealtrip, a travel tech company; Hokodo, a B2B buy-now-pay-later solution; and Rebellions, an AI chip designer. Korelya Capital aims to foster the emergence of global tech champions from Europe by providing not just capital but also strategic guidance and access to markets in Asia. Their approach focuses on deep-tech and digital transformation across various industries, ensuring robust support for their portfolio companies.

Korify Capital, based in Basel, Switzerland, focuses on early and growth-stage investments in the biotech sector, particularly targeting longevity and mental health. Launched by Robin and Peter Lauber’s family office, Infinitas Capital, Korify Capital aims to drive forward breakthrough technologies that can extend healthy lifespan and address mental health issues. Notable investments include Alto Neuroscience, which uses AI-derived brain biomarkers to develop psychiatric treatments, and Cambrian Biopharma, which is pioneering therapeutics to lengthen healthspan by targeting the biological drivers of aging. Another significant investment is Gameto, which focuses on improving assisted fertility and tackling ovarian aging through cellular reprogramming. Korify Capital also invests in companies like Refoxy, which develops medicines to treat age-related diseases by modulating stress response pathways, and Rejuveron, a biotech firm aiming to transform aging-related scientific discoveries into practical treatments. These investments demonstrate Korify’s commitment to supporting innovative approaches in the biotech field, aiming to enhance longevity and overall health. The firm’s strategy involves leveraging its extensive venture capital network and deep expertise in biotech to support these transformative companies, helping them achieve significant milestones and growth.

Kurma Partners is a prominent European venture capital firm based in Paris, specializing in healthcare and biotechnology investments. Founded in 2009, Kurma Partners has carved a niche in transforming cutting-edge scientific research into viable businesses. Their portfolio includes over 60 companies, with notable investments in Dynacure, Cardiologs, and IO Biotech. Focusing primarily on biotechnology, therapeutics, diagnostics, and health tech, Kurma Partners supports companies from early-stage seed funding to growth capital. They are particularly known for their deep collaboration with leading European research institutes, which helps them create startups based on groundbreaking scientific discoveries. This approach has resulted in the creation of more than 24 companies, many of which have become leaders in their fields. Geographically, Kurma Partners concentrates on Europe but has also made strategic investments in the United States. Their investment strategy includes both leading and participating in funding rounds, with typical investment sizes ranging from €1 million to €10 million, depending on the company's stage and needs. Kurma Partners' funds include the Kurma Biofund series and the Kurma Diagnostics funds, which emphasize innovative therapeutic and diagnostic solutions. The firm's leadership team boasts significant expertise, with key figures such as Thierry Laugel, Rémi Droller, and Sylvain Cascarino steering its strategic direction. They are actively involved in the portfolio companies, providing not just capital but also mentorship and industry connections. Kurma Partners is also committed to ESG principles, ensuring their investments align with ethical standards and contribute to sustainable development goals. For startups seeking investment, Kurma Partners recommends approaching them with a clear validation plan and leveraging their strong network of industry experts and entrepreneurs.

La Famiglia VC is a European venture capital firm based in Berlin, Germany, that specializes in seed and growth-stage investments in technology companies. The firm focuses on startups that enable or disrupt large industries, particularly in sectors such as AI, machine learning, data, logistics, supply chains, and fintech. Notable portfolio companies include Personio, Forto, Deel, Stripe, and Applied Intuition. The team at La Famiglia is led by co-founder Jeannette zu Fürstenberg, who drives the fund's vision and leverages her extensive network in the tech ecosystem. Other key team members include Judith Dada, known for her expertise in data and machine learning-driven business models, and Reda Awad, who focuses on investments in France and has a passion for payment systems. La Famiglia's investment strategy involves providing not only capital but also access to a network of world-leading entrepreneurs and industry experts, enabling early market access and impactful partnerships for their portfolio companies. They aim to support startups that have the potential to transform significant industries through technological innovation.​

Lakehouse Ventures, a venture capital firm based in New York City, was founded in 2016 by John Neamonitis. The firm specializes in seed-stage investments, focusing on innovative, technology-enabled businesses that aim to improve everyday life. Lakehouse Ventures supports founder-led companies during their earliest stages, offering not only financial backing but also strategic resources and networking opportunities to help them grow and succeed. Notable investments in Lakehouse Ventures' portfolio include Rhino, a SaaS-driven security deposit insurance platform for renters; Mixlab, an internet-first brand offering customized drugs for pets; and Billie, a brand of hair removal products for women, which was acquired in 2021. Other significant investments are in Base, a provider of at-home blood testing; Courted, an app and SaaS-driven network for real estate professionals; and Kingdom Supercultures, a food ingredients processing company based in Brooklyn. Lakehouse Ventures has a strong track record with 44 investments and several successful exits, including the personal care brand Billie and financial services company Harvest. The firm's approach focuses on high-conviction investments, typically leading equity financing rounds with check sizes ranging from $1 million to $2 million.

Lakestar, a venture capital firm founded in 2012 and headquartered in Zurich, specializes in early and growth-stage investments in technology-driven businesses. With a presence in Europe and the United States, Lakestar focuses on sectors like fintech, digitalization, deep tech, and healthcare. The firm has invested in over 150 companies, fostering disruptive innovations and supporting ambitious entrepreneurs. Notable investments in Lakestar's portfolio include major names like Spotify, the global music streaming giant; Revolut, a leading digital banking platform; and Airbnb, the renowned online marketplace for lodging. Other significant investments are in companies like Glovo, a fast-growing on-demand delivery service, and Neko Health, which focuses on advanced health monitoring and preventative care. Lakestar is known for its hands-on approach, providing not only capital but also strategic guidance and industry insights to help startups scale and achieve global success. The firm's investment range varies from €100,000 to over €5 million, catering to different stages of a company's lifecycle. Lakestar's founder, Dr. Klaus Hommels, and General Partner Manu Gupta, along with their team, leverage their extensive network and experience to support their portfolio companies. The firm is also deeply embedded in the European tech ecosystem, fostering connections between US and European companies and driving technological advancements.

Lansdowne Partners, founded in 1998 by Paul Ruddock and Steven Heinz, is a prominent investment management firm based in London. Initially known for its hedge fund strategies, Lansdowne has transitioned to focus more on long-only investment strategies. The firm has a notable history of significant investments and strategic shifts, particularly its recent move away from short-selling to concentrate on long-only funds. One of Lansdowne's major recent developments is the acquisition of CRUX Asset Management in 2023, expanding its capabilities in active equity management​​. The firm manages a variety of funds, including the Lansdowne Developed Markets Long-Only Fund and the Lansdowne Energy Dynamics Fund, which focuses on global renewable energy investments​. Lansdowne Partners' investment approach is rooted in rigorous fundamental research and a commitment to long-term performance. The firm is led by key figures such as Brian Heyworth, the current CEO, and Peter Davies, who heads the Developed Markets Strategy​​. This leadership team continues to guide Lansdowne through its evolving investment strategies and market conditions.

Launch Africa Ventures is a leading pan-African venture capital firm focused on addressing the funding gap for seed and pre-Series A startups across the continent. Founded in 2020 by Zachariah George and Janade du Plessis, Launch Africa has rapidly become one of the most active investors in the region. The firm has made significant investments in over 133 startups through its first fund, which raised $36.3 million by March 2022, and continues its momentum with a second fund that has invested $4.3 million into 16 startups across 11 African countries. Notable investments from Launch Africa include Bitmama, BFree, Chekkit, djamo, Gozem, Julaya, and Kuda. They focus on sectors such as fintech, logistics, health tech, and clean energy. Recent investments from their second fund feature startups like Servisor, Credit Circuit, and Shiprazor in South Africa; Lengo, Paps, and Solarbox in Senegal; Logistify and Octavia Carbon in Kenya; and Periculum and Kredete in Nigeria. Launch Africa's investment strategy emphasizes founder diversity, market potential, and geographical reach, supporting startups that have gone through renowned accelerator programs and display strong growth prospects. This approach not only helps in scaling these ventures but also contributes to the broader economic development of the African continent.

LaunchCapital, established in 2008, focuses on seed-stage investments and is backed by the Pritzker/Vlock Family Office. The firm has invested in over 200 companies, enabling entrepreneurs to build innovative businesses across various industries. Notable portfolio companies include Snapchat, Life360, and Formlabs, demonstrating their broad investment scope from consumer apps to advanced technology​​. LaunchCapital provides substantial support to its portfolio companies, emphasizing mentorship and strategic guidance. They typically invest during a company's first or second round of institutional funding and continue to support these companies through significant follow-on investments. Their approach is characterized by a commitment to milestones, capital efficiency, and a focus on developing both the entrepreneur and the business​​. With offices in Boston, New Haven, New York, and San Francisco, LaunchCapital maintains a national presence, ensuring they can support founders across the country. The firm's hands-on approach and strong network of advisors and entrepreneurs make it a valuable partner for startups looking to scale​.

Launchpad Venture Group is a prominent angel investment firm based in Boston, Massachusetts, focusing on early-stage technology and life science startups in the New England area. Since its inception in 2001, the firm has invested over $125 million in more than 150 startups, offering both financial support and human capital to foster growth and innovation. The firm’s portfolio includes a variety of sectors such as e-commerce, enterprise technology, healthcare, green technology, and education. Notable current investments include companies like ezCater, a corporate catering platform; Qstream, a mobile sales enablement and analytics tool; and RaySecur, which specializes in mail security through 3D scanning technology. Past successful exits include acquisitions of EnergySage by Schneider Electric and Localytics by Upland Software. Launchpad is renowned for its active angel network, providing startups with mentorship, strategic advice, and access to a wide range of industry connections. They focus on building long-term relationships with their portfolio companies, helping them scale and succeed in competitive markets​.

Lauxera Capital Partners is a healthcare-focused investment firm, specializing in growth-stage companies that are scientifically de-risked and have clear commercial pathways. Founded in 2020, the firm operates from Paris and San Francisco, with a focus on innovative healthcare sectors like medical devices, digital health, diagnostics, life sciences tools, and healthcare IT. They invest when startups have a proven revenue model and are ready to scale, contributing both capital and strategic expertise. Lauxera manages over €260 million through its Lauxera Growth I fund and typically invests between €300,000 and €3 million per startup. The firm is known for its hands-on approach, leveraging the operational experience of its team to support management in overcoming growth challenges and optimizing market adoption. Notable investments include Natural Cycles and Caresyntax, highlighting their commitment to cutting-edge health technologies​. Lauxera’s global perspective and strong European roots, combined with its healthcare expertise, make it a valuable partner for startups aiming to scale in large healthcare markets​.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.

Left Lane Capital is a prominent venture capital firm headquartered in Brooklyn, New York, with an additional office in London. Founded in 2019, the firm specializes in investing in high-growth internet and consumer technology companies. Their mission is to support companies that are driving the digitization of the real economy by providing them with actionable insights and operational support to achieve hyper-scale growth. The firm's investment portfolio includes notable companies such as GoStudent, Jackpocket, and Bilt Rewards. GoStudent is a Vienna-based digital marketplace for online tutoring, Jackpocket is a mobile lottery platform, and Bilt Rewards is a consumer finance and rewards company focused on property renters. Other significant investments include Talkiatry, a behavioral healthcare company, and Blinkist, a service that provides key insights from non-fiction books in audio and text formats. Left Lane Capital typically invests between $5 million and $75 million, often leading or co-leading rounds. They focus on sectors such as fintech, healthtech, e-commerce enablement, and SaaS, supporting both B2B and B2C business models. The firm prides itself on a data-driven approach and a deep understanding of their portfolio companies' markets and customers. The team is led by founder and CEO Harley Miller, along with managing partners Avneet Pujji, Daniel Ahrens, and Jason Fiedler. They bring extensive experience and a commitment to working closely with founders to navigate the challenges of scaling businesses.

Legend Capital, established in 2001, is a leading venture capital and private equity firm in China. The firm focuses on early-stage and growth-stage investments, managing over $10 billion in commitments. With a strong presence in Beijing, Shanghai, Shenzhen, Hong Kong, Seoul, and Singapore, Legend Capital has invested in around 600 companies across various sectors. Some of their notable investments include Pony.ai, which focuses on autonomous driving technology, and Beijing ESWIN Technology Group, a key player in semiconductor products and services. Legend Capital also supports companies like ZongmuTech in autonomous driving and Atour, a lifestyle accommodation brand. Additionally, they have invested in prominent companies like Bilibili, a leading video community, and Tuhu, an automotive consumer service platform. Legend Capital has a significant footprint in the life sciences sector, with portfolio companies like Recbio, a novel vaccines company, and Pharmaron, a leading contract research organization. Their investments are characterized by a focus on innovative technologies and solutions that drive industry advancements and address critical needs in the market. The firm is committed to providing comprehensive support to its portfolio companies, including governance, business strategy, R&D resources, and financial backing, helping them to scale and achieve long-term success.

Lerer Hippeau is a prominent seed-stage venture capital firm based in New York City. Founded in 2010, it has built a strong reputation for backing early-stage startups with transformative potential. The firm has invested in over 400 companies, including notable successes like Warby Parker, Allbirds, BuzzFeed, Oscar Health, and ClassDojo. Their portfolio spans various sectors, with significant investments in consumer products, enterprise software, healthcare, fintech, and media. Lerer Hippeau's investment strategy focuses on partnering with innovative founders and providing extensive support to help them grow. They typically invest in seed and early-stage rounds but also participate in follow-on investments to support the continued growth of their portfolio companies. The firm is known for its hands-on approach and deep network, which they leverage to help startups scale. Key figures at Lerer Hippeau include managing partners like Ben Lerer, Eric Hippeau, and Graham Brown, who bring a wealth of experience and industry insight. The firm is recognized for fostering a collaborative and founder-friendly culture, making it a preferred choice for many early-stage entrepreneurs looking for more than just capital. Lerer Hippeau’s notable unicorns include SeatGeek, ClassDojo, and Genies, among others. The firm has also seen several successful IPOs, including companies like Allbirds and Warby Parker, further establishing its reputation as a leading early-stage investor. For startups aiming to connect with Lerer Hippeau, it's beneficial to showcase innovative solutions with strong market potential, aligning with the firm’s focus on supporting transformative and high-growth ventures​.

LetsVenture, established in 2013, is a prominent platform in India's private market investment ecosystem, focusing on early-stage startups. The platform has facilitated over 900 investments, raising more than $250 million for startups, and is backed by notable figures like Ratan Tata and Mohandas Pai. LetsVenture supports a wide array of sectors including e-commerce, software, healthcare, and food and beverage. The platform's investment strategy includes seed and series A rounds, with significant investments in companies like Testbook.com, Innov8 Coworking, and Scripbox. LetsVenture operates through various verticals such as LetsVenture Early Stage, which connects investors with disruptive early-stage startups, and LetsVenture Debt, providing loans to startups for growth. They also offer trica equity, a solution for managing equity, cap tables, and ESOPs. LetsVenture has a robust network of over 20,000 investors and 500 family offices and VCs, making it a vital player in the Indian startup ecosystem. The platform also organizes the annual LetsIgnite event, one of India’s largest conclaves for startup investors, fostering connections and growth within the community​.

Lewis & Clark Ventures is an early-stage venture capital firm based in St. Louis, Missouri, specializing in B2B software investments. Founded by former founders and operators, the firm leverages its team's extensive entrepreneurial experience to partner with dynamic founders aiming to build successful companies. They focus on late seed to Series A investments, typically ranging from $2 million to $3 million per initial investment. The firm's portfolio includes innovative companies like Beam Benefits, Benson Hill, and GreenLight Biosciences. Lewis & Clark Ventures is known for its hands-on approach, often taking board seats and providing strategic, technical, and commercial support to help their portfolio companies scale effectively. Their investment strategy targets high-growth opportunities in overlooked geographies, emphasizing the importance of founder vision, team strength, and market potential. The firm values transparency, smart growth, and long-term partnerships, aiming to support founders not just with capital but also with mentorship and access to their extensive networks.

Lexi Ventures is a Menlo Park-based venture capital firm founded in 2023 by Jonah Probell, focused exclusively on seed-stage genetic engineering startups. Branded as Genetic Engineering Capital, the firm invests in US-based companies building around DNA, RNA, cells, and omics technologies. Probell brings 25 years of startup experience across seven companies in founder, executive, and engineering roles, having achieved two IPOs, 16 granted patents, and authored two books. The firm's thesis is that the genetic engineering revolution will be among the most value-creating venture categories of the next decade, as biology has transitioned from science to engineering. Lexi invests $50,000 to $500,000 with a sweet spot of $250,000, deploying approximately 10 investments annually and ranking among the top 20 VC funds active in the gene tech niche. The portfolio of 11-plus companies includes Kopra Bio (T-cell immunotherapy for solid tumors, most recent investment October 2025), ParcelBio (programmable mRNA delivery), KiraGen Bio (high-fidelity CRISPR tools, raised $2.5 million, Harvard Innovation Lab), QUiCKR Bio (gene editing quality control), Melio (rapid newborn pathogen diagnostics), AlkaLi Labs (biomining with microbes for critical minerals), Glyphic Bio (single-molecule protein sequencing), Syntensor (AI simulation for clinical trials), TippingPoint (precision genetic medicines for rare pediatric diseases), Taxa (bio-engineered probiotic skincare), and Crank Bio (RNA-based antisense therapeutics for rare diseases). Co-investors include IndieBio/SOSV and Activate Global. Lexi Ventures participates in the BIO Investor Forum and operates as a specialist conviction fund, aiming to be the first check for founders building at the frontier of genetic engineering. The firm's narrow focus gives it genuine domain depth — Probell evaluates deals not as a financial generalist but as someone who has built and scaled scientific companies from the lab bench outward.

LG Technology Ventures, founded in 2018 and based in Santa Clara, California, is the corporate venture capital arm of LG Group. The firm focuses on investing in early-stage companies across various sectors, including artificial intelligence, information technology, automotive, life sciences, and energy. With over $400 million in managed assets, LG Technology Ventures aims to drive innovation and growth by partnering with promising startups. Their portfolio includes notable investments in companies like H2O.ai, which offers an open-source machine learning platform; The Sandbox, a virtual metaverse game; and Moloco, which provides AI-enabled mobile DSP software. They have also invested in Element Energy, a battery technology company, and Eatron Technologies, specializing in AI for automotive and electric vehicles​​. The team at LG Technology Ventures consists of experienced investors, technologists, and industry experts, led by Dong-Su Kim, Ph.D., who serves as the CEO. The firm is known for its strategic approach, often leading investment rounds and providing substantial support to its portfolio companies to help them scale and succeed globally.​

Lightspeed Venture Partners is a prominent global venture capital firm that focuses on seed, early, and growth-stage investments across various sectors, including enterprise, fintech, consumer, and healthcare. Established in 2000, Lightspeed has raised significant capital over the years, including $4.2 billion in 2020 across three funds: an $890 million early-stage fund, a $1.83 billion growth fund, and a $1.5 billion opportunity fund. The firm has a robust portfolio with notable investments in companies like Snap, Nutanix, and Zscaler, reflecting its success in backing high-growth tech startups. Lightspeed has also been instrumental in the growth of other leading companies such as Affirm, MuleSoft, and The Honest Company. Their global reach includes offices in the United States, Israel, India, China, Southeast Asia, and Europe, enabling them to support entrepreneurs worldwide. Lightspeed's investment philosophy centers on deep engagement with their portfolio companies, offering not only capital but also strategic guidance and operational support. This hands-on approach helps startups navigate the challenges of scaling and achieving market leadership. Their commitment to building long-term relationships with founders and their focus on creating enduring companies sets them apart in the venture capital landscape.

Life.SREDA is a Singapore-based venture capital firm, established in 2012, that focuses exclusively on fintech investments. It was one of the first non-corporate VC funds to specialize in fintech, making significant strides in shaping the fintech landscape across Asia and globally. The firm has raised two major funds: Life.SREDA I ($40 million) and Life.SREDA II Asia ($100 million), which have enabled investments in over 20 fintech startups. These include well-known names like Simple, Moven, and Fidor, which are recognized for disrupting traditional financial services. Life.SREDA also manages the BB Fund, a blockchain-focused investment vehicle launched in 2016, further expanding its reach into emerging technologies. The fund targets companies involved in blockchain and cryptocurrency, reflecting its commitment to staying at the forefront of financial innovation. The firm's investment strategy focuses on early-stage companies in the fintech space, helping to nurture them through their growth stages and leading to multiple successful exits, such as Allset Technologies and Life Pay. Life.SREDA has built a reputation as a major player in the Asian fintech ecosystem and continues to invest in companies that are transforming financial services through technology.

LifeForce Capital, founded in 2015 and based in San Francisco, specializes in investing in healthcare companies that are advancing care delivery through innovative technologies and new care models. They focus on digital health startups that enable new therapeutic development and efficient care delivery. Some of their notable investments include Notable Labs, which leverages AI for precision oncology, Clover Health, a technology-driven health insurance company, and One Medical, a membership-based primary care platform. LifeForce Capital targets early to late-stage ventures, with a typical investment ranging from seed to Series B. They emphasize a software-first approach, aiming to drive a paradigm shift in healthcare. Their strategy involves supporting companies that offer scalable solutions with significant potential for improving patient outcomes and healthcare efficiency. The firm has a solid track record with successful exits such as Cricket Health and TARA Biosystems. The investment team, led by founder John Noonan, includes experts like Dr. Dora Hughes and Nathaniel Bays, who bring extensive experience in healthcare investment and operations. For entrepreneurs, LifeForce Capital looks for groundbreaking innovations that align with their mission to reshape healthcare. Startups are advised to present clear, impactful solutions that demonstrate potential for significant advancements in care delivery and therapeutic development​.

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

HV Ventures, also known as Lighthouse Ventures, is a venture capital firm based in Prague, Czech Republic, that focuses on early-stage investments. The firm is particularly active in the Central and Eastern European (CEE) region, supporting startups in sectors like financial services, logistics, and enterprise technology. Notable investments include 4Trans, Persoo, and AhoyConnect. LHV Ventures typically invests in seed and Series A rounds, with initial investments ranging from €200,000 to €3 million. They provide not only financial backing but also professional support through their extensive network and expertise in entrepreneurship, startup mentoring, and mergers and acquisitions. The firm is highly active in the local startup ecosystem, often co-investing with other prominent funds and leveraging support from initiatives like the Czech ESIF Fund of Funds to nurture promising startups. Key team members include Managing Partner Michal Zálešák, who brings a wealth of experience and leadership to the firm. LHV Ventures' approach emphasizes deep involvement with portfolio companies, helping them navigate challenges and scale effectively. Entrepreneurs looking to pitch to LHV Ventures should focus on demonstrating strong market potential and innovative solutions, particularly those that can scale globally from their base in the CEE region. The firm values thorough preparation and a clear understanding of the market dynamics. Overall, LHV Ventures is committed to fostering growth in the CEE startup ecosystem through strategic investments and active engagement with founders and their teams.

Lightrock is a global private equity firm that focuses on investing in sustainable businesses led by purpose-driven entrepreneurs. The firm aims to drive systemic change at scale through innovation, aligning its investments with impact themes such as "people," "planet," and "productivity/tech for good." Founded under the umbrella of LGT, Lightrock is committed to creating positive societal and environmental returns alongside financial gains​. Lightrock's diverse portfolio includes over 60 high-growth companies worldwide. Notable investments include Infarm, a rapidly growing urban farming network; PharmEasy, a leading omni-channel healthcare platform in India; and M-Kopa, a pioneer in pay-as-you-go solar energy services for off-grid customers in East Africa​. The firm actively supports its portfolio companies, often taking board positions to guide their dynamic growth and expansion. Headquartered in London, Lightrock operates globally with a team of more than 55 investment professionals across four continents, encompassing extensive experience in impact investing, leadership, and entrepreneurship. The firm is led by CEO Pal Erik Sjatil, the former Managing Partner of McKinsey & Company Europe​.

Lightspeed Venture Partners, founded in 2000, is a prominent global venture capital firm based in Menlo Park, California. The firm specializes in multi-stage investments, supporting companies from seed to growth stages. Lightspeed's investment focus spans several sectors, including enterprise, consumer, fintech, and healthcare. Some of Lightspeed's notable investments include Snapchat, Affirm, and Rubrik. Snapchat, a popular social media platform, went public in 2017, marking a significant success for the firm. Affirm, a financial technology company, also achieved a successful IPO in 2021. Rubrik, a leader in cloud data management, is another key company in their portfolio that highlights Lightspeed's focus on disruptive technology. Lightspeed Venture Partners has raised substantial funds over the years to support its diverse portfolio. In 2020, the firm raised $4.2 billion across three funds: an early-stage venture fund, a growth fund for later-stage investments, and an opportunity fund for doubling down on successful investments. The firm's philosophy centers on deep commitment and collaboration with founders, providing not just capital but also strategic guidance and support to help build enduring companies. With a global presence and a history of backing innovative companies, Lightspeed continues to be a key player in the venture capital landscape.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Lilly Asia Ventures (LAV) is a Shanghai-based biomedical venture capital firm founded in 2008 as the corporate venture arm of Eli Lilly before becoming fully independent in 2011, when it began raising third-party capital with Fund III. Headquartered in Shanghai with offices in Hong Kong and Palo Alto, LAV now manages approximately $4.5 billion in assets across seven funds. Fund VI closed at $1.35 billion in 2021, followed by Fund VII, which reached its $700 million hard cap. Managing Partner Yi Shi has led the firm since its founding, guiding its evolution from a corporate subsidiary into one of Asia's largest independent biomedical venture franchises. LAV invests globally across the full biomedical spectrum — from seed stage to publicly traded companies — in biopharmaceuticals, human therapeutics, medical devices, and diagnostics. The firm leads rounds and has made 326 total investments, achieving 54 portfolio exits. Among the most notable are NASDAQ IPOs for ArriVent, which reached a $575 million market cap in January 2024, and Alector, with a $1.3 billion market cap. Insilico Medicine became LAV's latest unicorn in 2025, exiting in December 2025 just three years after LAV's initial investment. Recent 2025 deals include StairMed Technology, Rona Therapeutics, EnChannel Medical, and a co-led $100 million Series C for Pulnova Medical. LAV's stated vision is to be the trusted partner for exceptional entrepreneurs seeking smart capital to build companies developing breakthrough health products. The firm brings deep scientific networks across Asia and North America, providing portfolio companies with access to clinical development expertise, regulatory knowledge, and global licensing relationships that are particularly valuable when bridging Asian and Western healthcare markets.

Lilly Ventures is the corporate venture capital arm of Eli Lilly and Company, based in Indianapolis, Indiana, and responsible for life science investing across North America and Europe. The fund manages approximately $200 million and operates as a therapeutically agnostic investor, backing companies from early to expansion stage across biotechnology, healthcare IT, and medical technology. It leads rounds and maintains a team of five professionals dedicated to identifying companies that can advance Lilly's drug discovery pipeline while also generating strong financial returns. In January 2025, Eli Lilly announced a landmark $500 million partnership with Andreessen Horowitz to create a new AI-focused biotech venture fund, signaling a major push into AI-driven drug development. The fund has made 84 investments and achieved an exceptional exit record of 36 exits, including 8 NASDAQ IPOs: BioAge Labs reached a $615 million market cap in September 2024, Kymeratx achieved an $863 million market cap, and Coherus Biosciences, Sutro Biopharma, and Protagonist Therapeutics have also gone public. The portfolio has also seen 19 acquisitions. Active portfolio companies include Insilico Medicine, an AI drug discovery firm that received Lilly Ventures' most recent investment in June 2025, alongside basys.ai and Evox Therapeutics. The fund also separately manages a $300 million Social Impact Venture Capital Portfolio targeting investments with measurable patient and societal benefit. Lilly Ventures operates as part of a broader Eli Lilly innovation ecosystem that includes Lilly Gateway Labs and Lilly ExploR&D, allowing portfolio companies to access laboratory infrastructure, scientific talent, and Lilly's global clinical and commercial networks. The fund's strategic alignment with Lilly's therapeutic priorities gives portfolio companies meaningful potential pathways to partnership and acquisition.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Listen Ventures, based in Chicago, is a venture capital firm dedicated to investing in consumer-focused brands. Founded in 2010, Listen Ventures operates with a unique approach by combining capital with brand strategy, creativity, and consumer insights to help entrepreneurs build impactful brands. The firm has raised $92 million across two funds: Listen Ventures III, a $62 million core fund for early-stage investments, and Listen Up, a $30 million opportunity fund for later-stage investments in its existing portfolio. Notable investments include brands like Calm, Catch Co, Dame, Factor, and Interior Define​. Listen Ventures emphasizes a concentrated investment strategy, preferring to invest larger amounts of capital and resources into fewer companies. This allows them to provide comprehensive support, including strategic and creative guidance. Their investment thesis centers on identifying shifts in cultural narratives and consumer behavior, backing brands that address these shifts effectively.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LiveOak Venture Partners, based in Austin, Texas, is a prominent venture capital firm dedicated to investing in early-stage tech and tech-enabled service companies primarily within Texas. Founded in 2012 by Krishna Srinivasan and Venu Shamapant, LiveOak has successfully positioned itself as a leading VC firm focused on nurturing Texas-based startups. The firm has raised three major funds, with the latest being a $210 million Fund III, which surpassed its initial target of $150 million. This makes it the largest Texas-focused early-stage VC fund raised in the past decade. LiveOak's investment strategy is centered on leading or co-leading seed, Series A, and occasionally pre-seed and growth-stage investments, with initial checks ranging from $500K to $10M. They focus on sectors like healthcare technology, information technology, and tech-enabled services. LiveOak's portfolio includes notable companies such as DISCO, OJO Labs, Digital Pharmacist, and Opcity. These companies have either achieved successful exits or have continued to grow under LiveOak’s guidance. The firm prides itself on being deeply involved with its portfolio companies, providing strategic advice, leveraging a vast network, and assisting in crucial hires and growth strategies. LiveOak's commitment to Texas is evident not only in its investment focus but also in its community initiatives like LiveOak Gives, which supports local non-profit organizations. This hands-on, community-oriented approach has helped LiveOak foster a thriving entrepreneurial ecosystem in Texas, contributing significantly to the region's economic growth.

LocalGlobe, founded by Robin and Saul Klein in 1999, is a leading venture capital firm based in London. The firm focuses on seed and early-stage investments, typically investing $0-1 million. LocalGlobe has built a strong reputation for supporting startups from their inception to successful Series A rounds, often within 15 to 18 months. LocalGlobe is known for its hands-on approach, leveraging a network of industry experts and mentors to help portfolio companies navigate early-stage challenges. The firm looks for founders with a strong vision and passion for their industry, prioritizing solutions that address significant real-world problems. This strategy has led to investments in some of the most transformative companies, such as fintech giants, digital banking solutions, and innovative technology firms. Their focus is primarily on the UK market, deploying about 80% of their capital locally. This commitment to nurturing local talent has solidified their position as one of the most influential seed investors in Europe. LocalGlobe's approach and strategic investments have significantly impacted the global startup ecosystem, making them a crucial player in the venture capital landscape.

Locus Ventures is a seed-stage venture capital firm founded by alumni from Google, Facebook, and Y Combinator. The firm focuses on investing in early-stage startups with the potential to create significant impact in various industries. Notable companies in their portfolio include Meesho, an online reselling platform; Ironclad, a contract lifecycle management software; and GitLab, a prominent DevOps platform that went public in 2021. Locus Ventures primarily invests in startups within the U.S. and Asia, leveraging their extensive experience and network in Silicon Valley and beyond. Their investment strategy emphasizes close collaboration with founders, providing guidance on product development and market strategy. They are known for their hands-on approach, often leading seed rounds and participating actively in the growth of their portfolio companies. The firm is led by partners Eric Kwan, William Chan, Perry Tam, and Tommy Tsai, who bring diverse backgrounds in technology and entrepreneurship. Locus Ventures has a track record of successful exits, including acquisitions by major companies such as Stripe and Nestlé.

Long Journey Ventures, founded in 2019 and based in San Francisco, focuses on early-stage investments across various sectors, including enterprise applications, consumer products, and emerging technologies. The firm has built an impressive portfolio featuring notable companies like Affirm, Uber, SpaceX, and Carta. They have also invested in innovative startups such as Flexport, Grove Collaborative, and Checkr. Long Journey Ventures typically invests in seed and Series A rounds, with an average round size of $17 million. Their strategy includes both leading and participating in funding rounds, providing strategic support and leveraging their extensive network to help startups scale. The firm has successfully nurtured nine unicorns, including Together AI, Crusoe, and Density. The leadership team includes experienced professionals like Cyan Banister, Lee Jacobs, and Arielle Zuckerberg, who bring deep expertise in venture investing and a strong track record of successful exits. Long Journey Ventures has been active with recent investments in sectors like satellite communication (Northwood Space) and cloud security (LimaCharlie), highlighting their commitment to supporting groundbreaking technologies and innovative business models.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Longevity Vision Fund (LVF) is a venture capital firm based in New York City, founded by Sergey Young. The fund focuses on investing in technologies and companies that aim to extend healthy human lifespans and address the negative effects of aging. With a $100 million fund, LVF supports innovations in preventive medicine, early detection, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. LVF's mission is to accelerate breakthroughs in longevity and make these advancements more accessible and affordable to the general public. Notable investments include Senda Biosciences, a company dedicated to developing treatments through its proprietary molecular platform. The fund is led by Sergey Young, a prominent figure in the longevity space with over 20 years of investment experience. Other key team members include Avetik Arakelyan, Sourav Sinha, and Kris Verburgh, who bring diverse expertise in healthcare, technology, and finance. LVF targets early-stage investments and partners with innovative companies worldwide, aiming to transform the life sciences and healthcare industries. They emphasize a long-term commitment to improving human health and promoting a healthier, longer life for everyone.

Longitude Capital is a healthcare-focused venture capital firm that invests across biotechnology, medical technology, and health solutions sectors. Established in 2006, the firm seeks out transformative companies that can improve clinical outcomes, enhance quality of life, and drive healthcare efficiencies. They invest across various stages, from startups to growth companies, with a unique focus on areas like oncology, neurodegenerative diseases, aging, and cardiovascular solutions. Longitude's approach is flexible, allowing them to invest in early clinical-stage companies, spin-outs, and even publicly traded firms. The firm is known for its involvement in special situations, including recapitalizations and PIPEs (Private Investment in Public Equity). They have a proven track record with successful IPOs and acquisitions, such as Aimmune Therapeutics, KaNDy Therapeutics, and Axonics Modulation Technologies. With $585 million raised in its latest fund (LVP4), Longitude Capital's strategy remains rooted in long-term value creation, bolstered by robust internal research teams. Their offices are located in Menlo Park, Greenwich, and Boston, and they continue to partner with both emerging and established healthcare innovators.

Longwall Ventures is a UK-based venture capital firm specializing in early-stage investments in the health, resilience, and sustainability sectors. Founded with a mission to support innovative startups, Longwall Ventures has a strong focus on companies that leverage science and engineering to create impactful solutions. Notable investments by Longwall Ventures include Wayland Additive, which develops advanced 3D printing technologies; Lightcast Discovery, a biotechnology firm; and Caristo Diagnostics, which focuses on cardiovascular diagnostics. The firm has also invested in Closed Loop Medicine, a company developing personalized drug and digital therapy combinations, and LettUs Grow, which specializes in vertical farming technology. Longwall Ventures is known for its hands-on approach, providing not only capital but also strategic support to its portfolio companies. With a diverse portfolio of over 40 companies, Longwall Ventures continues to play a crucial role in fostering innovation and supporting the growth of early-stage companies in the UK and beyond.

Longwood Fund, founded in 2010 and based in Boston, Massachusetts, is a venture capital firm specializing in creating and investing in science-based companies that develop novel solutions to address important medical needs. The fund's principals have co-founded 25 companies, serving as CEOs, Chief Business Officers, and lead investors, and have helped advance over 20 products to market. Longwood Fund's portfolio includes several notable companies such as Grail, which focuses on early cancer detection, and TScan Therapeutics, which develops novel T cell therapies for cancer. Other significant investments include Immunitas Therapeutics, a company using single-cell genomics to innovate in immune oncology, and Be Biopharma, which is developing engineered B cells as a new category of cellular medicines. The fund emphasizes a value-add investment approach, actively supporting its portfolio companies in accelerating clinical progress from lab to patient. With a strong track record of successful exits, including Pyxis Oncology and PTC Therapeutics, Longwood Fund continues to play a pivotal role in advancing healthcare innovations.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.